Author

Justine Galluso

Innate Pharma (France)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Amélie PouchiniD· 1 shared Angelika ModelskaiD· 1 shared Aurore Fenis· 1 shared Benjamin Rossi· 1 shared Bertrand Escalière· 1 shared Camille Baudesson de ChanvilleiD· 1 shared Émilie Narni-MancinelliiD· 1 shared Éric VivieriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amélie PouchinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing

Sophie Guia, Aurore Fenis, Camille Baudesson de Chanville, Justine Galluso, Hakim Medjouel Khlifi, Bertrand Escalière, Angelika Modelska, Margaux Vienne, Noëlla Lopes, Amélie Pouchin, Benjamin Rossi, Laurent Gauthier, Sandrine Roulland, Éric Vivier, Émilie Narni-Mancinelli

This study identifies ICAM-1 and IFN-γ signaling as critical factors influencing NK cell-mediated tumor cell destruction in HCT-116 cells.

Journal for ImmunoTherapy of Cancer · Mar 1, 2025Peer-reviewedImmunology